Martin McMorrow

755 total citations
10 papers, 537 citations indexed

About

Martin McMorrow is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Martin McMorrow has authored 10 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Martin McMorrow's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (2 papers). Martin McMorrow is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and HIV Research and Treatment (2 papers). Martin McMorrow collaborates with scholars based in Netherlands, United States and Japan. Martin McMorrow's co-authors include Marcel Beld, Jaap Goudsmit, Maarten Penning, Anneke van den Hoek, Vladimir V. Lukashov, Michael P. Manns, Hans Heiken, Hans L. Tillmann, Jill Detmer and Reinhold Schmidt and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Journal of Clinical Microbiology.

In The Last Decade

Martin McMorrow

9 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin McMorrow Netherlands 7 412 357 149 134 57 10 537
Bernd Goergen Germany 12 432 1.0× 429 1.2× 121 0.8× 105 0.8× 122 2.1× 15 638
Vinca Icard France 13 208 0.5× 275 0.8× 129 0.9× 242 1.8× 35 0.6× 18 555
Jeffrey C. Hunt United States 8 277 0.7× 284 0.8× 235 1.6× 190 1.4× 44 0.8× 11 490
J O Nielsen Denmark 12 201 0.5× 257 0.7× 124 0.8× 135 1.0× 74 1.3× 23 484
Joëlle Lerable France 9 299 0.7× 316 0.9× 114 0.8× 164 1.2× 28 0.5× 14 474
Sigrid Nick Germany 14 297 0.7× 445 1.2× 236 1.6× 151 1.1× 137 2.4× 33 645
Pantxika Bellecave France 12 222 0.5× 225 0.6× 206 1.4× 224 1.7× 76 1.3× 31 575
Roberto Fernandez-Larsson United States 7 185 0.4× 246 0.7× 110 0.7× 169 1.3× 69 1.2× 9 438
Mariacarmela Solmone Italy 13 364 0.9× 398 1.1× 99 0.7× 165 1.2× 54 0.9× 31 563
Caroline Scholtès France 20 915 2.2× 867 2.4× 72 0.5× 308 2.3× 50 0.9× 46 1.2k

Countries citing papers authored by Martin McMorrow

Since Specialization
Citations

This map shows the geographic impact of Martin McMorrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin McMorrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin McMorrow more than expected).

Fields of papers citing papers by Martin McMorrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin McMorrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin McMorrow. The network helps show where Martin McMorrow may publish in the future.

Co-authorship network of co-authors of Martin McMorrow

This figure shows the co-authorship network connecting the top 25 collaborators of Martin McMorrow. A scholar is included among the top collaborators of Martin McMorrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin McMorrow. Martin McMorrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Teoh, Zheyi, Ariana P. Toepfer, Chelsea Rohlfs, et al.. (2025). Viral Detection in Children <5 Years with Bronchiolitis, Pneumonia, and Croup, New Vaccine Surveillance Network, 2017-2023. Journal of the Pediatric Infectious Diseases Society. 14(11).
2.
Meiring, Susan, Jinal N. Bhiman, Jackie Kleynhans, et al.. (2022). Prolonged shedding of SARS-CoV-2 at high viral load amongst hospitalised immunocompromised persons living with HIV in South Africa. International Journal of Infectious Diseases. 116. S25–S25. 3 indexed citations
3.
Tillmann, Hans L., Hans Heiken, Stefan Heringlake, et al.. (2001). Infection with GB Virus C and Reduced Mortality among HIV-Infected Patients. New England Journal of Medicine. 345(10). 715–724. 283 indexed citations
4.
Sawyer, Lynette, et al.. (2000). Clinical laboratory evaluation of a new sensitive and specific assay for qualitative detection of hepatitis C virus RNA in clinical specimens. Journal of Hepatology. 32. 116–116. 18 indexed citations
5.
Hafez, Mohamed, Marcel Beld, Vladimir V. Lukashov, et al.. (1999). Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.. American Journal of Tropical Medicine and Hygiene. 60(4). 714–720. 25 indexed citations
7.
Beld, Marcel, Maarten Penning, Vladimir V. Lukashov, et al.. (1998). Evidence That both HIV and HIV-Induced Immunodeficiency Enhance HCV Replication among HCV Seroconverters. Virology. 244(2). 504–512. 95 indexed citations
8.
Beld, Marcel, Maarten Penning, Martin McMorrow, et al.. (1998). Different Hepatitis C Virus (HCV) RNA Load Profiles Following Seroconversion among Injecting Drug Users without Correlation with HCV Genotype and Serum Alanine Aminotransferase Levels. Journal of Clinical Microbiology. 36(4). 872–877. 40 indexed citations
9.
Beld, Marcel, Maarten Penning, Anneke van den Hoek, et al.. (1998). Hepatitis C Virus Serotype-Specific Core and NS4 Antibodies in Injecting Drug Users Participating in the Amsterdam Cohort Studies. Journal of Clinical Microbiology. 36(10). 3002–3006. 10 indexed citations
10.
McMorrow, Martin, et al.. (1995). Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clinical & Experimental Immunology. 102(1). 131–136. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026